---
title: Press-Releases - 2021-06-13-0530
layout: podcast
categories: [Press-Releases]
type: main
description: Plato Syndication is Brought to you by Plato Data Intelligence.
file: "https://plato-audiostream.s3.amazonaws.com/archive/Press-Releases_en-2021-06-13-0530.mp3" 
length: "20:18"
tags: [patients,European Hematology,Hematology Association,First,registered,Survival,chronic lymphocytic,lymphocytic leukemia,New,Treatment,CGTN,China,]
show: "Press-Releases"
excerpt_separator: <!--more-->
cover: "https://plato-audiostream.s3.amazonaws.com/images/Press-Releases_en-2021-06-13-0530.png"
# feature-img: "https://plato-audiostream.s3.amazonaws.com/images/Press-Releases_en-2021-06-13-0530.png"
thumbnail: "https://plato-audiostream.s3.amazonaws.com/images/Press-Releases_en-2021-06-13-0530.png"
---

Here comes: Press-Releases
<!--more-->
## Press-Releases

----  



June 13, 04:18 (America New York)

### CGTN: China to build Zhejiang into demonstration zone for common prosperity  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/cgtn-china-to-build-zhejiang-into-demonstration-zone-for-common-prosperity-301311277.html){:target="_blank"}  

----  


June 12, 22:00 (America New York)

### Marcus Ericsson, Honda Win Opening Round of Detroit Doubleheader  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/marcus-ericsson-honda-win-opening-round-of-detroit-doubleheader-301311271.html){:target="_blank"}  

----  


June 12, 18:50 (America New York)

### Inauguration of the PowerLook Franchise in Manaus is a success  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/inauguracao-da-franquia-powerlook-em-manaus-e-um-sucesso-848804684.html){:target="_blank"}  

----  


June 12, 16:34 (America New York)

### Inauguration of the PowerLook Franchise in Manaus is a success  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/inauguracao-da-franquia-powerlook-em-manaus-e-um-sucesso-826922086.html){:target="_blank"}  

----  


June 12, 15:40 (America New York)

### The packages sent by Colombians from abroad are threatened  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/amenazada-la-paqueteria-que-envian-los-colombianos-desde-el-exterior-842700869.html){:target="_blank"}  

----  


June 12, 14:44 (America New York)

### At SNEC 2021, Risen Energy presented the first mass-produced 700 W high-efficiency NewT @ N power supply module  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/spolecnost-risen-energy-predstavila-na-veletrhu-snec-2021-prvni-masove-vyrabeny-700-w-vysoce-ucinny-napajeci-modul-newt-n-837924493.html){:target="_blank"}  

----  


June 12, 14:38 (America New York)

### Risen Energy Introduces NewT @ N High Efficiency 700W Power Module at SNEC 2021  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/risen-energy-predstavliaet-700-vattnyi-silovoi-modul-newt-n-s-vysokim-kpd-na-snec-2021-856577682.html){:target="_blank"}  

----  


June 12, 14:08 (America New York)

### Huawei Digital Power wants to build a competent global partner community for a green and bright future  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/spolecnost-huawei-digital-power-touzi-po-vybudovani-kompetentni-globalni-partnerske-komunity-pro-ekologickou-a-zarivou-budoucnost-877146992.html){:target="_blank"}  

----  


June 12, 14:02 (America New York)

### Huawei Digital Power is committed to building a full-fledged global partner community  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/huawei-digital-power-stremitsia-k-sozdaniiu-polnopravnogo-vsemirnogo-soobshchestva-partnerov-806246035.html){:target="_blank"}  

----  


June 12, 13:51 (America New York)

### Freshpet Voluntarily Recalls One Lot of Freshpet:registered: Select Small Dog Bite Size Beef ï¼† Egg Recipe Dog Food Due to Potential Salmonella Contamination  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/freshpet-voluntarily-recalls-one-lot-of-freshpet-select-small-dog-bite-size-beef--egg-recipe-dog-food-due-to-potential-salmonella-contamination-301311252.html){:target="_blank"}  

----  


June 12, 13:38 (America New York)

### Alzheimer's Association Statement: Next Steps For New Alzheimer's Treatment  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/alzheimers-association-statement-next-steps-for-new-alzheimers-treatment-301311251.html){:target="_blank"}  

----  


June 12, 13:23 (America New York)

### CGTN: Former French Prime Minister Highlights Innovative Ideas in Chinese Leader&#39;s Book  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/cgtn-byvshii-prem-er-ministr-frantsii-otmetil-novatorskie-idei-v-knige-kitaiskogo-lidera-812231029.html){:target="_blank"}  

----  


June 12, 13:05 (America New York)

### CGTN: What is behind the great aspirations of the Chinese youth?  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/cgtn-que-hay-detras-de-las-grandes-aspiraciones-de-la-juventud-china--855224406.html){:target="_blank"}  

----  


June 12, 13:00 (America New York)

### SKT to Participate in E3 2021 to Showcase Exciting Korean Games  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/skt-to-participate-in-e3-2021-to-showcase-exciting-korean-games-301310785.html){:target="_blank"}  

----  


June 12, 12:52 (America New York)

### CGTN: What is behind young Chinese people's lofty ambitions?  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/cgtn-what-is-behind-young-chinese-peoples-lofty-ambitions-301311249.html){:target="_blank"}  

----  


June 12, 10:00 (America New York)

### Jimmy Mistry Launches Della Leaders Club, World's First Business Platform, Helping Leaders Evolve from a Life of Success to A Life of Significance  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/jimmy-mistry-launches-della-leaders-club-worlds-first-business-platform-helping-leaders-evolve-from-a-life-of-success-to-a-life-of-significance-301311182.html){:target="_blank"}  

----  


June 12, 09:34 (America New York)

### HARMONY presents new findings in chronic lymphocytic leukemia (CLL) at the EHA2021 Virtual Congress  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/harmony-prasentiert-neue-erkenntnisse-bei-chronischer-lymphatischer-leukamie-cll-auf-dem-eha2021-virtual-congress-818249327.html){:target="_blank"}  

----  


June 12, 09:31 (America New York)

### HARMONY Presents New Data on Chronic Lymphocytic Leukemia (CLL) at EHA2021 Virtual Congress  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/harmony-presente-de-nouvelles-donnees-sur-la-leucemie-lymphoide-chronique-llc-au-congres-virtuel-eha2021-836808226.html){:target="_blank"}  

----  


June 12, 09:16 (America New York)

### Rick Barnett is Recognized As NACD Directorship Certified:trade_mark:  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/rick-barnett-is-recognized-as-nacd-directorship-certified-301311175.html){:target="_blank"}  

----  


June 12, 09:04 (America New York)

### Sustained growth in production even during the pandemic: VVDN announces measures  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/anhaltendes-wachstum-der-fertigung-auch-in-der-pandemie-vvdn-gibt-massnahmen-bekannt-803640990.html){:target="_blank"}  

----  


June 12, 09:01 (America New York)

### VVDN announces action as manufacturing industry growth continues despite pandemic  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/vvdn-annonce-des-mesures-alors-que-la-croissance-de-l-industrie-manufacturiere-se-poursuit-en-depit-de-la-pandemie-869965581.html){:target="_blank"}  

----  


June 12, 07:31 (America New York)

### Did You Acquire (QS) Before November 27, 2020? Johnson Fistel Investigates QuantumScape; Should Management be Held Accountable for Investors Losses?  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/did-you-acquire-qs-before-november-27-2020-johnson-fistel-investigates-quantumscape-should-management-be-held-accountable-for-investors-losses-301311240.html){:target="_blank"}  

----  


June 12, 07:05 (America New York)

### China to deepen reform, opening-up, expand cooperation in new era  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/china-to-deepen-reform-opening-up-expand-cooperation-in-new-era-301311238.html){:target="_blank"}  

----  


June 12, 07:02 (America New York)

### IMBRUVICA:registered: (ibrutinib) Plus VENCLEXTA:registered:/VENCLYXTO:registered: (venetoclax) Combination Shows Superior Progression-Free Survival Compared to Chlorambucil Plus Obinutuzumab in First-line Chronic Lymphocytic Leukemia (CLL) Phase 3 GLOW Study  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/imbruvica-ibrutinib-plus-venclextavenclyxto-venetoclax-combination-shows-superior-progression-free-survival-compared-to-chlorambucil-plus-obinutuzumab-in-first-line-chronic-lymphocytic-leukemia-cll-phase-3-glow-study-301311176.html){:target="_blank"}  

----  


June 12, 07:00 (America New York)

### Janssen Announces Results from Phase 3 MAIA Study Showing Significant Overall Survival Benefits for Treatment with DARZALEX:registered: (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma Who are Transplant Ineligible  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/janssen-announces-results-from-phase-3-maia-study-showing-significant-overall-survival-benefits-for-treatment-with-darzalex-daratumumab-in-patients-with-newly-diagnosed-multiple-myeloma-who-are-transplant-ineligible-301311235.html){:target="_blank"}  

----  


June 12, 07:00 (America New York)

### New Phase 3 Study Results Show IMBRUVICA:registered: (ibrutinib)-Based Combination Regimen as an All-Oral Fixed-Duration Treatment Demonstrated Superior Progression-Free Survival in Adult Patients with Previously Untreated Chronic Lymphocytic Leukemia  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/new-phase-3-study-results-show-imbruvica-ibrutinib-based-combination-regimen-as-an-all-oral-fixed-duration-treatment-demonstrated-superior-progression-free-survival-in-adult-patients-with-previously-untreated-chronic-lymphocyti-301311195.html){:target="_blank"}  

----  


June 12, 06:42 (America New York)

### Looking for answers: An American communist explores China  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/looking-for-answers-an-american-communist-explores-china-301311237.html){:target="_blank"}  

----  


June 12, 06:04 (America New York)

### Expert: Tariff warfare against China is futile  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/expert-tariff-warfare-against-china-is-futile-301311231.html){:target="_blank"}  

----  


June 12, 04:20 (America New York)

### Perfect World to pioneer digital culture and creative sector in joint hands with partners  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/perfect-world-to-pioneer-digital-culture-and-creative-sector-in-joint-hands-with-partners-301311222.html){:target="_blank"}  

----  


June 12, 03:26 (America New York)

### Daiki Axis Co., Ltd. (4245, First Section, Tokyo Stock Exchange) Overview of Operating Performance for the First Three Months Ended March 31, 2021  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/daiki-axis-co-ltd-4245-first-section-tokyo-stock-exchange-overview-of-operating-performance-for-the-first-three-months-ended-march-31-2021-301311218.html){:target="_blank"}  

----  


June 12, 03:00 (America New York)

### European Hematology Association: Humoral response to Pfizer / BioNTech BNT162b2 vaccine is impaired in patients receiving CAR-T or high-intensity immunosuppressive therapy  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/european-hematology-association-humorale-reaktion-auf-den-pfizer-biontech-bnt162b2-impfstoff-ist-bei-patienten-die-eine-car-t-oder-hochintensive-immunsuppressive-therapie-erhalten-beeintrachtigt-888933081.html){:target="_blank"}  

----  


June 12, 03:00 (America New York)

### European Hematology Association (EHA) - Administration of daratumumab improves progression-free survival after autologous stem cell transplantation in patients with multiple myeloma  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/european-hematology-association-eha-l-administration-de-daratumumab-ameliore-la-survie-sans-progression-apres-une-transplantation-autologue-de-cellules-souches-chez-les-patients-atteints-de-myelome-multiple-853231772.html){:target="_blank"}  

----  


June 12, 03:00 (America New York)

### European Hematology Association - The first-line Ibrutinib + Venetoclax combination is more effective than the Chlorambucil + Obinutuzumab combination for the treatment of chronic lymphocytic leukemia and small lymphocyte lymphoma  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/european-hematology-association-l-association-ibrutinib-venetoclax-en-premiere-ligne-est-plus-efficace-que-l-association-chlorambucil-obinutuzumab-pour-le-traitement-de-la-leucemie-lymphoide-chronique-et-le-lymphome-a-petits-lymphocytes-841668130.html){:target="_blank"}  

----  


June 12, 03:00 (America New York)

### European Hematology Association: Overall survival benefit established with daratumumab plus lenalidomide and dexamethasone (D-Rd) in elderly patients with newly diagnosed multiple myeloma (NDMM) not eligible for transplant  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/european-hematology-association-benefice-de-survie-globale-etabli-avec-le-daratumumab-plus-lenalidomide-et-dexamethasone-d-rd-chez-les-patients-ages-atteints-d-un-myelome-multiple-nouvellement-diagnostique-ndmm-non-eligible-a-la-transplanta-861615488.html){:target="_blank"}  

----  


June 12, 03:00 (America New York)

### European Hematology Association: Ibrutinib + venetoclax as initial treatment for chronic lymphocytic leukemia / small cell lymphocytic lymphoma works better than chlorambucil + obinutuzumab  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/european-hematology-association-ibrutinib-venetoclax-als-erstbehandlung-bei-chronischer-lymphatischer-leukamie-kleinzelligem-lymphozytischem-lymphom-wirkt-besser-als-chlorambucil-obinutuzumab-860075812.html){:target="_blank"}  

----  


June 12, 03:00 (America New York)

### European Hematology Association: Overall Survival Benefit Established With Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) in Elderly Patients with Transplant-ineligible Newly Diagnosed Multiple Myeloma (NDMM): Long-Term Interim Analysis of the MAI  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/european-hematology-association-overall-survival-benefit-established-with-daratumumab-plus-lenalidomide-and-dexamethasone-d-rd-in-elderly-patients-with-transplant-ineligible-newly-diagnosed-multiple-myeloma-ndmm-long-term-in-301310175.html){:target="_blank"}  

----  


June 12, 03:00 (America New York)

### EHA: Efficacy of the Pfizer / BioNTech BNT162b2 vaccine in patients receiving CAR-T  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/eha-eficacia-de-la-vacuna-pfizer-biontech-bnt162b2-en-pacientes-que-reciben-car-t-868759422.html){:target="_blank"}  

----  


June 12, 03:00 (America New York)

### European Association of Hematology (AEH) - Pegcetacoplan maintains a sustainable response in patients with paroxysmal nocturnal hemoglobinuria at week 48  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/association-europeenne-d-hematologie-aeh-le-pegcetacoplan-maintient-une-reponse-durable-chez-les-patients-atteints-d-hemoglobinurie-paroxystique-nocturne-a-la-semaine-48-895575202.html){:target="_blank"}  

----  


June 12, 03:00 (America New York)

### European Hematology Association - Pegcetacoplan shows sustained response in patients with paroxysmal nocturnal hemoglobinuria through week 48  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/european-hematology-association-pegcetacoplan-zeigt-ein-dauerhaftes-ansprechen-bei-patienten-mit-paroxysmaler-nachtlicher-hamoglobinurie-bis-woche-48-869158155.html){:target="_blank"}  

----  


June 12, 03:00 (America New York)

### EHA: Pegcetacoplan maintains a long-lasting response in patients with paroxysmal nocturnal hemoglobinuria  

#### PR Newswire:

  

[Read More](https://www.prnewswire.com/news-releases/eha-pegcetacoplan-mantiene-una-respuesta-duradera-en-pacientes-con-hemoglobinuria-paroxismal-nocturna-823646542.html){:target="_blank"}  

----  
  